The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

 
Web www.patentalert.com

> Hepatitis C virus inhibitors

~ 00355